Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Gepotidacin in Japanese Females with Uncomplicated UTI
NCT05630833Phase 3Completed
- Sponsor
- GSK
- Start
- Jan 2023
- Primary completion
- Feb 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of gepotidacin in urinary tract infection (UTI), sponsored by GSK. Started Jan 2023; status: completed.
02
Drugs
gepotidacin
03
Conditions
urinary tract infection (UTI)
Beyond the preview
Go deeper on NCT05630833.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05630833.